<p><img src="https://static1.businessinsider.com/image/609045c334af8d001859a9bb-2222/429A6303.jpg" border="0" alt="Albert Bourla CEO of Pfizer 1" data-mce-source="Crystal Cox/Insider"></p><p></p><bi-shortcode id="summary-shortcode" data-type="summary-shortcode" class="mceNonEditable" contenteditable="false">Summary List Placement</bi-shortcode><p>Pfizer outlined a busy 2021 for its coronavirus vaccine on Tuesday, as executives for the drugmaker projected the shot will bring in $26 billion in revenues on the year. </p><p>Even though the shot is already authorized in the US and elsewhere, there's tons of research going on to expand the vaccine's impact. In particular, Pfizer is studying the vaccine in children of all ages, going all the way down to babies. The company also expects to have data this year for a new version of its shot that doesn't need to kept at any unusually low temperatures.</p><p>Pfizer's shot, co-developed with the German biotech BioNTech, was the first COVID-19 vaccine authorized in the US. More than 130 million doses have been administered in the US so far, <a href="https://covid.cdc.gov/covid-data-tracker/#vaccinations">according to the Centers for Disease Control and Prevention</a>. </p><p>One slide in Pfizer's earnings presentation on Tuesday summarizes the cascade of news the New York pharmaceutical giant expects over the next few months:</p><p><img src="https://static3.businessinsider.com/image/609149faf22c6b00185db6e3-2144/Screen Shot 2021-05-04 at 91534 AM.png" border="0" alt="Pfizer's 2021 timeline for coronavirus vaccine development" data-mce-source="Pfizer" data-mce-caption="Pfizer's 2021 timeline for coronavirus vaccine development, presented on May 4, 2021."></p><h2>Gearing up for more authorizations through the end of 2021</h2><p>In May, Pfizer plans to submit for full approval in the US.</p><p>Currently, regulators issued an emergency use authorization (EUA) for the shot. Full approval would give Pfizer more ability to market and promote its vaccine, and <a href="https://www.businessinsider.com/should-the-covid-19-vaccine-be-mandated-in-us-immunization-campaign-2021-4">some organizations could also feel more confident in requiring the shot once it's fully approved</a>.</p><p>Pfizer also expects to launch a new study in May, in which the COVID-19 vaccine is given alongside its experimental pneumococcal conjugate vaccine. The pneumococcal vaccine <a href="https://www.pfizer.com/news/press-release/press-release-detail/us-fda-accepts-priority-review-biologics-license">is under FDA review</a> and is expected to make an approval decision by June.</p><p>The summer will bring another flurry of updates for Pfizer's vaccine. The company plans to apply for an emergency OK for its vaccine as a booster shot, and also produce data in August for a new version of the vaccine that could be stable for up to 10 weeks with just typical refrigeration.</p><p>The <a href="https://www.businessinsider.com/pfizer-is-developing-powder-version-of-its-covid-19-vaccine-2020-11">cold-storage requirements were an initial challenge</a> facing Pfizer's shot, although newer data shows the current vaccine is stable with normal refrigeration for up to four weeks. </p><p>Finally, Pfizer is hoping it will be able to roll out its vaccine into the pediatric population throughout 2021. The company is currently waiting on an FDA decision to OK the shot for ages 12-15. The vaccine is currently authorized for use in anyone 16 years old and up. </p><p>In September, Pfizer anticipates clinical trial results showing whether or not the shot works in children aged 2-11. The final step down for kidsfrom 6-month-old babies to 2-year-oldsshould produce data in November, according to Pfizer's projections.</p><p><a href="https://www.businessinsider.com/pfizers-coronavirus-vaccine-2021-timeline-for-children-trials-2021-5#comments">Join the conversation about this story »</a></p> <p>NOW WATCH: <a href="https://www.businessinsider.com/lufthansa-cargo-covid-19-vaccine-shipping-logistics-preparation-cold-storage-2020-12">How Lufthansa Cargo will ship up to 10 million COVID-19 vaccine doses a day</a></p> Click here to read full news..